March 13 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO :
* ARALEZ ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS
* TOTAL REVENUE FOR Q4 OF 2017 WERE $28.0 MILLION, AN INCREASE OF $8.0 MILLION, OR 40%, COMPARED TO $20.0 MILLION FOR SAME PERIOD OF 2016
* QTRLY LOSS PER SHARE $0.68
* 2018 NET REVENUES TO BE IN A RANGE OF $140 MILLION TO $160 MILLION
* SEES 2018 ADJUSTED EBITDA TO BE IN A RANGE OF $35 MILLION TO $55 MILLION